Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: L-cysteine toxicity

This article was originally published in The Tan Sheet

Executive Summary

L-cysteine toxicity: Tyson and Associates submits June 14 letter to FDA in support of a generally recognized as safe (GRAS) petition filed by Skymart Enterprises for L-cysteine. After conducting a literature review, Tyson concluded that "L-cysteine should essentially be taken under a doctor's supervision for children under 12 years old, and that it should not be removed from the marketplace. However, providing a better professional nutritional safe dose is recommended." Tyson previously conducted a literature search to support the safety of amino acids ("The Tan Sheet" Aug. 30, 1993, p. 16)...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS084019

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel